PL365576A1 - S-Metylodihydrozyprasydon do leczenia chorób psychiatrycznych i chorób oczu - Google Patents

S-Metylodihydrozyprasydon do leczenia chorób psychiatrycznych i chorób oczu

Info

Publication number: PL365576A1
Authority: PL; Poland
Prior art keywords: ziprasidone; psychiatric; dihydro; methyl; treatment
Prior art date: 2000-06-02

Application number

PL01365576A

Other languages

English (en)

Inventor

Chandra Aggarwal Prakash

Teresa Annette Smolarek

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2001-05-28

Publication date

2005-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL365576(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-28 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2005-01-10 Publication of PL365576A1 publication Critical patent/PL365576A1/pl

Links

NHUDBVVEHOSVCD-UHFFFAOYSA-N 6-chloro-5-[2-[4-(2-methylsulfanylbenzenecarboximidoyl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one Chemical compound CSC1=CC=CC=C1C(=N)N1CCN(CCC=2C(=CC=3NC(=O)CC=3C=2)Cl)CC1 NHUDBVVEHOSVCD-UHFFFAOYSA-N 0.000 title 1
208000022873 Ocular disease Diseases 0.000 title 1
208000020016 psychiatric disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Hydrogenated Pyridines (AREA)

PL01365576A 2000-06-02 2001-05-28 S-Metylodihydrozyprasydon do leczenia chorób psychiatrycznych i chorób oczu PL365576A1 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20913600P	2000-06-02	2000-06-02
US21217200P	2000-06-16	2000-06-16
PCT/IB2001/000933 WO2001091756A2 (en)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders

Publications (1)

Publication Number	Publication Date
PL365576A1 true PL365576A1 (pl)	2005-01-10

Family

ID=26903852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01365576A PL365576A1 (pl)	2000-06-02	2001-05-28	S-Metylodihydrozyprasydon do leczenia chorób psychiatrycznych i chorób oczu

Country Status (44)

Country	Link
US (1)	US20060287336A1 (pl)
EP (3)	EP1698338B1 (pl)
JP (2)	JP2003534381A (pl)
KR (1)	KR20030007824A (pl)
CN (1)	CN1431901A (pl)
AP (2)	AP1747A (pl)
AR (1)	AR028937A1 (pl)
AT (3)	ATE391507T1 (pl)
AU (1)	AU2001258690A1 (pl)
BG (1)	BG107267A (pl)
BR (1)	BR0111271A (pl)
CA (1)	CA2410618A1 (pl)
CY (1)	CY1105992T1 (pl)
CZ (1)	CZ20023860A3 (pl)
DE (3)	DE60133596D1 (pl)
DK (1)	DK1468686T3 (pl)
DO (1)	DOP2001000181A (pl)
EA (1)	EA007068B1 (pl)
EC (1)	ECSP024369A (pl)
EE (1)	EE200200670A (pl)
ES (1)	ES2277170T3 (pl)
GE (1)	GEP20053512B (pl)
HN (1)	HN2001000119A (pl)
HR (1)	HRP20020953A2 (pl)
HU (1)	HUP0301747A2 (pl)
IL (2)	IL152782A0 (pl)
IS (1)	IS6619A (pl)
MA (1)	MA26908A1 (pl)
MX (1)	MXPA02011862A (pl)
NO (1)	NO325077B1 (pl)
NZ (1)	NZ551012A (pl)
OA (1)	OA12267A (pl)
PA (1)	PA8518301A1 (pl)
PE (1)	PE20011329A1 (pl)
PL (1)	PL365576A1 (pl)
PT (2)	PT1698338E (pl)
SI (1)	SI1468686T1 (pl)
SK (1)	SK16622002A3 (pl)
SV (1)	SV2002000473A (pl)
UA (1)	UA79425C2 (pl)
UY (1)	UY26742A1 (pl)
WO (1)	WO2001091756A2 (pl)
YU (1)	YU90702A (pl)
ZA (1)	ZA200209665B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003296991A1 (en)	2002-12-13	2004-07-09	Regents Of The University Of Minnesota	Scleral depressor
WO2005040160A2 (en)	2003-10-24	2005-05-06	Teva Pharmaceutical Industries Ltd.	Processes for preparation of ziprasidone
ES2250001B1 (es) *	2004-09-29	2007-06-01	Medichem, S.A.	Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) *	2011-02-24	2012-09-10	Kyocera Corp	プログラム保護装置および通信装置
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
US9981041B2 (en) *	2016-08-23	2018-05-29	Ira Jason Salzman	Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW491847B (en) *	1996-05-07	2002-06-21	Pfizer	Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
ATE236902T1 (de) *	1996-05-07	2003-04-15	Pfizer	Mesylat des trihydrats des 5-(2-(4-(1,2- benzothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor 1,3-dihydro-2(1h)-indol-2-ons (=ziprasidon), seine herstellung und seine anwendung als dopamin d2 antagonist
ATE247963T1 (de) *	1998-05-26	2003-09-15	Pfizer Prod Inc	Medikament zur behandlung von glaukoma und ischämischer retinopathie
WO2000059489A2 (en) *	1999-04-06	2000-10-12	Sepracor Inc.	Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites

2001
- 2001-05-28 EP EP06116051A patent/EP1698338B1/en not_active Expired - Lifetime
- 2001-05-28 IL IL15278201A patent/IL152782A0/xx active IP Right Grant
- 2001-05-28 JP JP2001587771A patent/JP2003534381A/ja not_active Withdrawn
- 2001-05-28 ES ES04013380T patent/ES2277170T3/es not_active Expired - Lifetime
- 2001-05-28 PT PT06116051T patent/PT1698338E/pt unknown
- 2001-05-28 DE DE60133596T patent/DE60133596D1/de not_active Expired - Lifetime
- 2001-05-28 AT AT06116051T patent/ATE391507T1/de not_active IP Right Cessation
- 2001-05-28 WO PCT/IB2001/000933 patent/WO2001091756A2/en not_active Ceased
- 2001-05-28 EA EA200201168A patent/EA007068B1/ru not_active IP Right Cessation
- 2001-05-28 GE GE4972A patent/GEP20053512B/en unknown
- 2001-05-28 EP EP01932011A patent/EP1286672B1/en not_active Expired - Lifetime
- 2001-05-28 SI SI200130681T patent/SI1468686T1/sl unknown
- 2001-05-28 DE DE60124093T patent/DE60124093D1/de not_active Expired - Lifetime
- 2001-05-28 CN CN01810620A patent/CN1431901A/zh active Pending
- 2001-05-28 DE DE60124791T patent/DE60124791T2/de not_active Expired - Fee Related
- 2001-05-28 YU YU90702A patent/YU90702A/sh unknown
- 2001-05-28 KR KR1020027016364A patent/KR20030007824A/ko not_active Ceased
- 2001-05-28 CZ CZ20023860A patent/CZ20023860A3/cs unknown
- 2001-05-28 DK DK04013380T patent/DK1468686T3/da active
- 2001-05-28 OA OA1200200349A patent/OA12267A/en unknown
- 2001-05-28 AT AT01932011T patent/ATE343387T1/de not_active IP Right Cessation
- 2001-05-28 NZ NZ551012A patent/NZ551012A/en unknown
- 2001-05-28 AU AU2001258690A patent/AU2001258690A1/en not_active Abandoned
- 2001-05-28 PT PT04013380T patent/PT1468686E/pt unknown
- 2001-05-28 PL PL01365576A patent/PL365576A1/pl unknown
- 2001-05-28 HR HR20020953A patent/HRP20020953A2/hr not_active Application Discontinuation
- 2001-05-28 CA CA002410618A patent/CA2410618A1/en not_active Abandoned
- 2001-05-28 BR BR0111271-6A patent/BR0111271A/pt not_active Application Discontinuation
- 2001-05-28 HU HU0301747A patent/HUP0301747A2/hu unknown
- 2001-05-28 EP EP04013380A patent/EP1468686B1/en not_active Expired - Lifetime
- 2001-05-28 EE EEP200200670A patent/EE200200670A/xx unknown
- 2001-05-28 SK SK1662-2002A patent/SK16622002A3/sk not_active Application Discontinuation
- 2001-05-28 AT AT04013380T patent/ATE345818T1/de not_active IP Right Cessation
- 2001-05-28 MX MXPA02011862A patent/MXPA02011862A/es active IP Right Grant
- 2001-05-28 UA UA2002119557A patent/UA79425C2/uk unknown
- 2001-05-31 AP AP2005003272A patent/AP1747A/xx active
- 2001-05-31 HN HN2001000119A patent/HN2001000119A/es unknown
- 2001-05-31 UY UY26742A patent/UY26742A1/es not_active Application Discontinuation
- 2001-05-31 PE PE2001000504A patent/PE20011329A1/es not_active Application Discontinuation
- 2001-05-31 AP APAP/P/2001/002180A patent/AP1831A/en active
- 2001-05-31 DO DO2001000181A patent/DOP2001000181A/es unknown
- 2001-06-01 SV SV2001000473A patent/SV2002000473A/es not_active Application Discontinuation
- 2001-06-01 AR ARP010102641A patent/AR028937A1/es unknown
- 2001-06-01 PA PA20018518301A patent/PA8518301A1/es unknown
- 2001-06-04 US US09/873,973 patent/US20060287336A1/en not_active Abandoned
2002
- 2002-11-11 IL IL152782A patent/IL152782A/en not_active IP Right Cessation
- 2002-11-12 BG BG107267A patent/BG107267A/bg unknown
- 2002-11-14 IS IS6619A patent/IS6619A/is unknown
- 2002-11-28 ZA ZA200209665A patent/ZA200209665B/en unknown
- 2002-11-29 NO NO20025760A patent/NO325077B1/no unknown
- 2002-11-29 EC EC2002004369A patent/ECSP024369A/es unknown
- 2002-11-29 MA MA26927A patent/MA26908A1/fr unknown
2007
- 2007-02-08 CY CY20071100161T patent/CY1105992T1/el unknown
- 2007-11-14 JP JP2007296039A patent/JP2008056700A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
BR0111271A (pt)	2003-06-10
IL152782A0 (en)	2003-06-24
DE60124791D1 (de)	2007-01-04
DE60124791T2 (de)	2007-09-13
IS6619A (is)	2002-11-14
HRP20020953A2 (en)	2005-02-28
DOP2001000181A (es)	2002-04-15
PE20011329A1 (es)	2002-01-15
OA12267A (en)	2004-01-20
KR20030007824A (ko)	2003-01-23
DE60124093D1 (de)	2006-12-07
JP2003534381A (ja)	2003-11-18
EP1468686A3 (en)	2004-12-01
BG107267A (bg)	2003-06-30
CA2410618A1 (en)	2001-12-06
MA26908A1 (fr)	2004-12-20
EE200200670A (et)	2004-08-16
CZ20023860A3 (cs)	2004-01-14
AP1831A (en)	2008-02-26
ATE391507T1 (de)	2008-04-15
AU2001258690A1 (en)	2001-12-11
EP1468686A2 (en)	2004-10-20
HUP0301747A2 (hu)	2003-09-29
AP1747A (en)	2007-05-31
PT1468686E (pt)	2007-01-31
AR028937A1 (es)	2003-05-28
CN1431901A (zh)	2003-07-23
DE60133596D1 (de)	2008-05-21
SK16622002A3 (sk)	2004-07-07
NO20025760L (no)	2003-01-15
EP1698338A3 (en)	2006-09-20
JP2008056700A (ja)	2008-03-13
ECSP024369A (es)	2003-02-06
ES2277170T3 (es)	2007-07-01
MXPA02011862A (es)	2003-04-10
EP1286672B1 (en)	2006-10-25
ATE343387T1 (de)	2006-11-15
EA007068B1 (ru)	2006-06-30
SV2002000473A (es)	2002-10-24
NZ551012A (en)	2008-04-30
EP1468686B1 (en)	2006-11-22
PT1698338E (pt)	2008-06-03
IL152782A (en)	2007-10-31
US20060287336A1 (en)	2006-12-21
ATE345818T1 (de)	2006-12-15
WO2001091756A3 (en)	2002-09-26
SI1468686T1 (sl)	2007-04-30
DK1468686T3 (da)	2007-03-12
PA8518301A1 (es)	2002-09-17
EP1286672A2 (en)	2003-03-05
AP2005003272A0 (en)	2005-03-31
NO20025760D0 (no)	2002-11-29
ZA200209665B (en)	2003-11-28
UA79425C2 (en)	2007-06-25
HN2001000119A (es)	2001-09-11
NO325077B1 (no)	2008-01-28
CY1105992T1 (el)	2011-04-06
EP1698338B1 (en)	2008-04-09
YU90702A (sh)	2005-11-28
EA200201168A1 (ru)	2003-06-26
UY26742A1 (es)	2001-12-28
WO2001091756A2 (en)	2001-12-06
EP1698338A2 (en)	2006-09-06
GEP20053512B (en)	2005-05-10

Legal Events

Date	Code	Title	Description
2010-04-30	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
HUP0400914A3 (en)	2007-05-29	Methods of treatment of mitochondrial disorders
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU8187701A (en)	2002-01-14	Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
PL366636A1 (pl)	2005-02-07	Piranoindazole i ich zastosowanie w leczeniu jaskry
IL151890A0 (en)	2003-04-10	Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL156340A0 (en)	2004-01-04	3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
AU2001271887A1 (en)	2002-01-21	Methods for diagnosis and treatment of psychiatric disorders
AU3840802A (en)	2002-06-03	Methods and compositions for the treatment of diseases of the eye
AU2001256855A1 (en)	2001-11-20	Preparation for the prevention and treatment of ocular disorders
IL155433A0 (en)	2003-11-23	Treatment of t cell disorders
EP1404326A4 (en)	2004-06-30	METHOD FOR THE TREATMENT OF PARKINSON DISEASE
AU2002362115A8 (en)	2003-07-24	Composition and methods for treatment of neurological disorders
IL151765A0 (en)	2003-04-10	Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB9926968D0 (en)	2000-01-12	Treatment of neurological disorders
IL155874A0 (en)	2003-12-23	Treatment of anxiety disorders
IL152782A0 (en)	2003-06-24	S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
GB2360453B (en)	2004-09-01	Treatment of skin conditions
AR026062A1 (es)	2002-12-26	Tratamiento de desordenes oculares
HUP0102886A3 (en)	2002-12-28	Treatment of anxiety disorders
GB9901808D0 (en)	1999-03-17	Drugs for treatment of psychiatric and brain disorders
AU2001236909A1 (en)	2001-08-20	Method of treating disorders of the eye
GB0029955D0 (en)	2001-01-24	Treatment of neuropsychiatric disorders
GB0017951D0 (en)	2000-09-13	Treatment of movement disorders
HK1063438A (en)	2004-12-31	Treatment of anxiety disorders